Alzheimer's disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugs.
Douglas BartholdZachary A MarcumShelly L GrayJulie ZissimopoulosPublished in: Pharmacoepidemiology and drug safety (2020)
Non-selective and M3-selective BAM users had similar odds of ADRD incidence, and BAM use overall was significantly associated with ADRD incidence.